| Application no. and date | 12715362.5 (espacenet) (Federated) (European Patent Register), 20120412 | | Patent/reg. no. and date | DK/EP 2697218, 20160525 | | Publication date | 20140219 | | Priority no. and date | US 201161474936 P, 20110413 | | EP pub. no. and date |
EP 2697218 20140219 | | Effective date | | | Applicant/owner | Janssen Pharmaceutica NV, Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | P58742DK01 | | Inventor | HOUPIS, Ioannis, Nicolaos, c/o Janssen Pharmaceutica NV
Turnhoutseweg 30
B-2340 Beerse, BE,
LEMAIRE, Sebastien, François, Emmanuel, c/o Janssen Pharmaceutica NV
Turnhoutseweg 30
B-2340 Beerse, BE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07D 409/10 (2006.01) , C07D 409/14 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLINGEN AF FORBINDELSER ANVENDELIGE SOM INHIBITORER AF SGLT2 | | Int. application no. | EP2012056649 | | Int. publication no. | WO2012140120 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
